Patent 7947649 was granted and assigned to Advanced Technologies and Regenerative Medicine, LLC on May, 2011 by the United States Patent and Trademark Office.
Improved formulations and methods are provided for stabilizing a solution of bone morphogenetic protein. The compositions comprise an acetate buffered solution of GDF-5 and other excipients wherein the solution has a pH of from about 4.2 to about 5.3, thereby providing for a biologically isotonic solution having improved stability of the GDF-5 protein during storage, handling, and use.